Mrs D complained about the care and treatment provided to her by Swansea Bay University Health Board. The Ombudsman considered whether the investigations conducted by the Health Board into a suspected neuroendocrine tumour (“NET” – a rare form of cancer that affects the cells that release hormones into the bloodstream) were appropriate and timely.
The investigation found that the investigations conducted by the Health Board into a suspected NET were appropriate and timely. Although there had been some contradictory findings from tests and procedures that had prolonged the treatment pathway, follow up investigations were clinically appropriate. The investigation found no evidence of unnecessary delays and that Mrs D had been informed of the findings and the plans. The Ombudsman did not uphold the complaint.